The Current Ratio as of December 2024 (TTM) for Pieris Pharmaceuticals, Inc. (PIRS) is 4.82

According to Pieris Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.82. This represents a change of 21.12% compared to the average of 3.98 of the last 4 quarters.

Pieris Pharmaceuticals, Inc. (PIRS) Historical Current Ratio (quarterly & annually)

How has PIRS Current Ratio performed in the past?

The mean historical Current Ratio of Pieris Pharmaceuticals, Inc. over the last ten years is 4.10. The current 4.82 Current Ratio has changed 11.66% with respect to the historical average. Over the past ten years (40 quarters), PIRS's Current Ratio was at its highest in in the September 2015 quarter at 15.23. The Current Ratio was at its lowest in in the March 2023 quarter at 1.41.

Pieris Pharmaceuticals, Inc. (PIRS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pieris Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pieris Pharmaceuticals, Inc. (PIRS) Average Current Ratio

How has PIRS Current Ratio performed in the past?

The current Current Ratio of Pieris Pharmaceuticals, Inc. (PIRS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pieris Pharmaceuticals, Inc. (PIRS) Current Ratio vs. Peers

How is PIRS’s Current Ratio compared to its peers?

Pieris Pharmaceuticals, Inc.’s Current Ratio is greater than Adaptimmune Therapeutics plc (3.85), less than Mereo BioPharma Group plc (6.10), greater than PDS Biotechnology Corporation (2.84), greater than Leap Therapeutics, Inc. (3.97), less than X4 Pharmaceuticals, Inc. (4.89), greater than Corvus Pharmaceuticals, Inc. (0.92), less than Terns Pharmaceuticals, Inc. (32.99), greater than TCR2 Therapeutics Inc. (2.77), greater than Affimed N.V. (1.93), less than ADC Therapeutics SA (4.92), greater than Agenus Inc. (0.19), less than Inozyme Pharma, Inc. (7.68), less than Achilles Therapeutics plc (6.04), greater than Checkpoint Therapeutics, Inc. (0.29), greater than Cue Biopharma, Inc. (2.22), less than Medicenna Therapeutics Corp. (11.40),

Build a custom stock screener for Pieris Pharmaceuticals, Inc. (PIRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pieris Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pieris Pharmaceuticals, Inc. (PIRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pieris Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.